%0 Journal Article
%T USE OF INHIBITORS  OF TYPE 2 SODIUM-GLUCOSE COTRANSPORTER  FOR THE CARDIOPROTECTION  IN THE PATIENTS UNDERGOING POTENTIALLY TOXIC ANTI-TUMOR THERAPY. REVIEW OF LITERATURE
%A Salukhov, V.V.
%A PUZhALOV, I.A.
%A SANTAKOV, A.A.
%A VARAVIN, N.A.
%K anthracyclines, inhibitors of type 2 sodium-glucose cotransporter (SGLT2i), cardiac oncology, cardiac protection, cardiotoxicity, anti-tumor therapy
%J Medical Bulletin of the Ministry of Internal Affairs
%D 2025
%N 2025
%P 6
%I State institution Joint editorial office of the Ministry of Internal Affairs of Russia